Vision loss in giant cell arteritis

被引:10
|
作者
Donaldson, Laura [1 ]
Margolin, Edward [1 ]
机构
[1] Univ Toronto, Dept Ophthalmol & Vis Sci, Fac Med, Toronto, ON, Canada
关键词
neuro-ophthalmology; ophthalmology; vasculitis; ISCHEMIC OPTIC NEUROPATHY; VISUAL MANIFESTATIONS; CLINICAL SPECTRUM; RISK;
D O I
10.1136/practneurol-2021-002972
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Almost two-thirds of patients with giant cell arteritis (GCA) develop ocular symptoms and up to 30% suffer permanent visual loss. We review the three most common mechanisms for visual loss in GCA, describing the relevant ophthalmic arterial anatomy and emphasising how ophthalmoscopy holds the key to a rapid diagnosis. The short posterior ciliary arteries supply the optic nerve head, while the central retinal artery and its branches supply the inner retina. GCA has a predilection to affect branches of posterior ciliary arteries. The most common mechanism of visual loss in GCA is anterior arteritic optic neuropathy due to vasculitic involvement of short posterior ciliary arteries. The second most common cause of visual loss in GCA is central retinal artery occlusion. When a patient aged over 50 years has both anterior ischaemic optic neuropathy and a central retinal artery occlusion, the diagnosis is GCA until proven otherwise, and they should start treatment without delay. The least common culprit is posterior ischaemic optic neuropathy, resulting from vasculitic involvement of the ophthalmic artery and its pial branches. Here, the ophthalmoscopy is normal acutely, but MR imaging of the orbits usually shows restricted diffusion in the optic nerve.
引用
收藏
页码:138 / +
页数:4
相关论文
共 50 条
  • [1] Postural vision loss in giant cell arteritis
    Diego, M
    Margo, CE
    JOURNAL OF NEURO-OPHTHALMOLOGY, 1998, 18 (02) : 124 - 126
  • [2] Treatment of Vision Loss in Giant Cell Arteritis
    Ryan A. Scheurer
    Andrew R. Harrison
    Michael S. Lee
    Current Treatment Options in Neurology, 2012, 14 : 84 - 92
  • [3] Treatment of Vision Loss in Giant Cell Arteritis
    Scheurer, Ryan A.
    Harrison, Andrew R.
    Lee, Michael S.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2012, 14 (01) : 84 - 92
  • [4] Slowly progressive vision loss in giant cell arteritis
    Galor, A
    Lee, MS
    ARCHIVES OF OPHTHALMOLOGY, 2006, 124 (03) : 416 - 418
  • [5] Predictors of Permanent Vision Loss in Giant Cell Arteritis
    Tucker, Susan M.
    Haas, Sara J.
    Rizvi, Tasneem Zaihra
    NEURO-OPHTHALMOLOGY, 2024,
  • [6] Risk for Vision Loss and Relapse in Patients with Giant Cell Arteritis
    Haaversen, Anne Bull
    Diamantopoulos, Andreas
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [7] Vision loss in patients with giant cell arteritis treated with tocilizumab
    Amsler, Jennifer
    Kysela, Iveta
    Tappeiner, Christoph
    Seitz, Luca
    Christ, Lisa
    Scholz, Godehard
    Stalder, Odile
    Kollert, Florian
    Reichenbach, Stephan
    Villiger, Peter M.
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [8] Vision loss in patients with giant cell arteritis treated with tocilizumab
    Jennifer Amsler
    Iveta Kysela
    Christoph Tappeiner
    Luca Seitz
    Lisa Christ
    Godehard Scholz
    Odile Stalder
    Florian Kollert
    Stephan Reichenbach
    Peter M. Villiger
    Arthritis Research & Therapy, 23
  • [9] Vision loss in giant cell arteritis: case-based review
    Ioanna Nefeli Kokloni
    Souzana Ioanna Aligianni
    Olga Makri
    Dimitrios Daoussis
    Rheumatology International, 2022, 42 : 1855 - 1862
  • [10] Vision loss in giant cell arteritis: case-based review
    Kokloni, Ioanna Nefeli
    Aligianni, Souzana Ioanna
    Makri, Olga
    Daoussis, Dimitrios
    RHEUMATOLOGY INTERNATIONAL, 2022, 42 (10) : 1855 - 1862